Daiwa Securities Upgrades Merck (MRK) to Outperform (2)

Daiwa Securities analyst Narumi Nakagiri upgraded Merck (NYSE: MRK) from Neutral (3) to Outperform (2) with a price target of $143.00 (from $120.00).

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $130.42 yesterday.

You May Also Be Interested In

• Macquarie Upgrades Hankook Tire Co Ltd (161390:KS) to Outperform
• Oppenheimer Upgrades Intuitive Surgical (ISRG) to Outperform, 'Crowding Out Competitors Strategically Smart'
• Lemon Tree Hotels (LEMONTRE:IN) PT Raised to INR180 at Macquarie